SCHEMBL9619085

SCHEMBL9619085

CCCc1nc(NN(C)C)nc(N2CCOCC2)n1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
GAA P10253 2/20 0.45
KDM4E B2RXH2 1/20 0.45
HSD17B10 Q99714 1/20 0.44
TSHR P16473 2/20 0.42
TP53 P04637 1/20 0.42
HRH4 Q9H3N8 1/20 0.42
MAPK1 P28482 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9619171 0.85 SMN1; SMN2 (0.57) ALDH1A1MEN1KMT2AGAAKDM4E
Hydrochloric Acid SCHEMBL10418857 0.83 SMN1; SMN2 (0.56) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL9619145 0.83 GAA (0.50) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL9619292 0.81 KDM4E (0.49) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL8798665 0.80 NPSR1 (0.46) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL9619146 0.79 KDM4E (0.55) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL9619063 0.79 KDM4E (0.52) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL3365592 0.79 CYP1A2 (0.56) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL9619069 0.77 MEN1 (0.49) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL9619183 0.77 KDM4E (0.50) ALDH1A1MEN1KMT2AGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0356412-B1 USE OF 2-AMINO-4-MORPHOLINO-6-PROPYL-1,3,5-TRIAZINES IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF COGNITIVE AND MENTAL DISORDERS U C B, S.A. (BE) 1992-05-13 EP claimed
EP-0356413-B1 2-AMINO-4-MORPHOLINO-6-PROPYL-1,3,5-TRIAZINES U C B, S.A. (BE) 1992-01-29 EP claimed
US-4956363-A 2-amino-4-morpholino-6-propyl-1,3,5-triazine U C B S.A. (BE) 1990-09-11 US claimed
US-4956367-A COGNITION ACTIVATORS, ALZHEIMER*S DISEASE U C B S.A. (BE) 1990-09-11 US claimed
EP-0356412-A1 Use of 2-amino-4-morpholino-6-propyl-1,3,5-triazines in the preparation of a medicament for the treatment of cognitive and mental disorders U C B, S.A. (BE) 1990-02-28 EP claimed
EP-0356413-A1 2-Amino-4-morpholino-6-propyl-1,3,5-triazines U C B, S.A. (BE) 1990-02-28 EP claimed
EP-0356412-B1 USE OF 2-AMINO-4-MORPHOLINO-6-PROPYL-1,3,5-TRIAZINES IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF COGNITIVE AND MENTAL DISORDERS U C B, S.A. (BE) 1992-05-13 EP disclosed
EP-0356413-B1 2-AMINO-4-MORPHOLINO-6-PROPYL-1,3,5-TRIAZINES U C B, S.A. (BE) 1992-01-29 EP disclosed
US-4956363-A 2-amino-4-morpholino-6-propyl-1,3,5-triazine U C B S.A. (BE) 1990-09-11 US disclosed
US-4956367-A COGNITION ACTIVATORS, ALZHEIMER*S DISEASE U C B S.A. (BE) 1990-09-11 US disclosed
EP-0356412-A1 Use of 2-amino-4-morpholino-6-propyl-1,3,5-triazines in the preparation of a medicament for the treatment of cognitive and mental disorders U C B, S.A. (BE) 1990-02-28 EP disclosed
EP-0356413-A1 2-Amino-4-morpholino-6-propyl-1,3,5-triazines U C B, S.A. (BE) 1990-02-28 EP disclosed